-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-eligible-disabled_research.pdf
June 01, 2011 - “Acute Inpatient” hospitalizations and days are defined
as hospitalizations in acute care hospitals … We calculated average covered days as the
average number of days spent over the ini-
tial six-month … ) and
incomplete duals (36.4 days) than for
partial and nonduals (28 and 23.2 days,
respectively). … 7.4 7.2 7.8 5.7
Other Inpatient - Average Covered Days 15.8 14.1 16.7 14.3
Skilled Nursing Facility … Hospice - Average Covered Days 90.5 84.9 86.0 84.5
Evaluation & Management - Average # of Part
B
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/knowledge-brief-2-methods-public-deliberation-130213.pdf
February 01, 2013 - l
M
at
er
ia
ls
R
ec
ru
itm
en
t
M
et
ho
d
Citizens’ Juries In Person 12–24 1 4–7 days … Yes Yes No Randomly
selected
Planning Cells In Person 25 1 4–7 days Yes Yes Yes Purposively
selected … Issues Forums Both 2–100 1 1–14
days
No N/A Yes Purposively
selected
Consensus
Conferences … Both 10–20 1 2–3 days Yes Yes Yes Randomly
selected
Deliberative Polling Both ® 130–450 1 1–2 days
-
effectivehealthcare.ahrq.gov/sites/default/files/knowledge-brief-2-methods-public-deliberation-130213.pdf
February 01, 2013 - l
M
at
er
ia
ls
R
ec
ru
itm
en
t
M
et
ho
d
Citizens’ Juries In Person 12–24 1 4–7 days … Yes Yes No Randomly
selected
Planning Cells In Person 25 1 4–7 days Yes Yes Yes Purposively
selected … Issues Forums Both 2–100 1 1–14
days
No N/A Yes Purposively
selected
Consensus
Conferences … Both 10–20 1 2–3 days Yes Yes Yes Randomly
selected
Deliberative Polling Both ® 130–450 1 1–2 days
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-1.xlsx
January 01, 2009 - -Patients were treated daily for up to 3 days
-During the 3 days of study observation, labor induction … Next dose was given 3-4 days later to coincide with next antepartum testing visit. at the next visit … -Application of study gel was not performed more frequently than every 3 to 4 days, even if the patient … -Patients returned to the clinic within 3 to 4 days for a second dose of PGE2. … : 18.7%
-39 wks to 39 wks and 6 days: 21.6%
-40 wks to 40 wks and 6 days: 43.9%
-41 wks to 41 wks and
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - a diagnosis of RA.26
Potential cohort members were required to have known
gender and at least 365 days … Under TennCare
mandate, prescriptions are generally filled for a time interval
no longer than 30 days … death, loss of enrollment, diagnosis of serious
illness, stopping a specific DMARD (greater than 90 days … Although previous studies of NSAIDs use applied
similar 90 days periods to define drug discontinuation … Data on
medication use during hospitalizations are not available in
TennCare databases and days in the
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-rapid-research.pdf
April 01, 2024 - with incidence density of
1.58 per 1,000 patient-days at hospital A, versus 145 events in 92,741 patient-days … infection (incidence density of 0.19 per 1,000 patient-days
at hospital A versus 0.16 per 1,000 patient-days … ; p<0.001) and non-ICU
patients (0.12 vs 0.07 MRSA HAI per 1000 patient-days; p=0.01). … vs 0.02 per 1000
patient-days, p=0.01). … per 1,000 patient-days in the implementation period (53 positive
cultures, 63,860 patient-days, over
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
July 01, 2025 - ; 3-5 days past month 8.2 percent; and 6 or more
days past month 9.3 percent. … past month
16.4%, misused 3-6 days past month
9.1%, 7 or more days past month
6.2%. … Mean days past month
marijuana use 11.71
(11.90). … Mean days past
month alcohol use 7.35
(6.50). … : Past year: 30%
misused 1 or 2 days , 70% misused 3
or more days
Mode of administration: NR
Health
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - LOS- 4 days. … Median time to event: DVT
alone – 70 days; PE alone – 46 days; DVT and PE – 31
days. … Days of post-operative
drainage ( OR=1.32) • Days of drainage (Saleh) ? … and 7 days respectively … • Dahl (2000) – mean duration to VTE symptoms was
27 days for THR. 17 days for TKR and 36 days for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
November 03, 2011 - Headache Foundation defines chronic migraine as headache, tension-type or migraine, that
occurs >15 days … migraine attacks per month,
1
while others suggest it for those
who experience a headache on most days … o Emergency visits, loss of work or school days; treatment failure. … Intermediate outcomes:
o Number of headache days. … o Number of moderate to severe headache days.
o Improvement in associated symptoms.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
July 01, 2010 - carotid stenting; factors associated with the use of carotid
revascularization; and mortality at 30 days … In 2005, mortality was 1.2% at 30 days and 6.8% at 1 year for
endarterectomy and 2.3% at 30 days and … Mortality
We summarized all-cause mortality at 30 days and 1 year for beneficiaries who
underwent … In 2005, 845 (1.2%) died
within 30 days of the index procedure and 4766 (6.8%) died within 1 year. … Among patients who
underwent carotid stenting, 178 (2.3%) died within 30 days of the index procedure
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-provider-adherence_research-protocol.pdf
March 02, 2012 - million people (8.2%) currently have asthma.1 Students
with asthma miss more than 14 million school days … , missed days of school and/or work, quality of life,
emergency department visits/hospitalizations/urgent … peak flow
meter
Follow-up visits
Unintended consequences
Clinical Outcomes
Symptom days … www.effectivehealthcare.ahrq.gov
Published Online: March 2, 2012
6
outcomes include: symptom days … , missed days of school and/or work, quality of life, emergency department visits/hospitalizations/urgent
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
June 01, 2012 - “Acute Inpatient” hospitalizations and days are
defined as hospitalizations in acute care hospitals … We calculated average covered days as the
average number of days spent over the
initial six-month period … We see some dramatic differ-
ences, such as with the average number of SNF days, which were 39.7
for … (Average Covered Days)
39.7 28.2 39.7 20.4
Home Health
(Average Number of Visits)
35.4 34.7 25.3 … 15.8
Hospice
(Average Covered Days)
93.5 69.0 80.6 75.5
Evaluation and Management
(Average # of
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - prolongs
or requires hospitalization for more than 48 hours or results in re-hospitalization within 30 days … ACC/AHA Key Data
Elements (1)
Survival Procedure-related
death
All-cause mortality within 30 days … of patients with AF:
Paroxysmal AF: AF that terminates spontaneously or with intervention within 7 days … Persistent AF: Continuous AF that is sustained >7 days. … be excluded from this measure
as it relates to prolonged hospitalization or readmission within 30 days
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-2ndplace-paws.pdf
May 29, 2025 - symptoms are getting better or
worse will help decide if an antibi-
otic is needed in the next 2-3 days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin-future_research.pdf
August 01, 2014 - ≥ 30 days)
Hospital
ICU
ES-6
Table A. … ≥ 30 days)
• Ambulator
y care
• Primary
care clinic
• ED
ES-7
Table A. … ≥ 30 days)
Hospital
ICU
16
Table 4. … ≥ 30 days)
• Ambulatory
care
• Primary
care clinic
• ED
17
Table 4. … 2 days shorter than recommended.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-outcome-measure-harmonization-depression.pdf
November 01, 2020 - Timeframe for measurement:
• 6 months (+/- 60 days)
• 12 months (+/- 60 days)
In some implementations … Timeframe for measurement:
• 6 months (+/- 60 days)
• 12 months (+/- 60 days)
In some implementations … Timeframe for measurement:
• 6 months (+/- 60 days)
• 12 months (+/- 60 days)
In some implementations … Events of
Interest
Suicide Ideation
& Behavior
Selection of “several days,” “more than half the … days,” or “nearly every day”
option on PHQ-9 item 9 (“Thoughts that you would be better off dead or
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
September 01, 2010 - patient-reported outcomes measured with the same
quality of life indices for KQ1 and KQ2, including days … measures to include other patient-reported outcomes that
could reflect quality of life including days … KQ4 will focus on patient-
reported outcomes, including quality of life and days of work or school missed … Certolizumab Pegol Cimzia Subcutaneous ~14 days TNF inhibitor Yes No
Biologic Natalizumab Tysabri … Intravenous 7-15 days
Prevents attachment of
inflammatory immune
cells to intestinal cell
layers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - Antibiotic use outcomes that were considered distinct
included duration of antibiotic therapy in days … , rate of antibiotic
prescription as a proportion, and total antibiotic exposure in number
of days … on antibiotics per total patient-days for an entire group as a
rate. … and page 65 fo 283): “Only one
study reported an absolute increase in antibiotic duration
of 0.1 days … reported smaller effects (-2.0 days,
-1.7 days).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_executive.pdf
January 27, 2012 - , heavy drinking
days, drinks per drinking day, accidents, injuries, QoL or
function, mortality, and … Some disulfiram
trials reported fewer drinking days for subjects who
returned to any drinking and who … First, for topiramate, we found moderate SOE
supporting efficacy for reducing drinking days, heavy … drinking days (WMD, -11.5; 95% CI [confidence interval],
-18.3 to -4.8), and drinks per drinking day … Most studies required patients to abstain for at least a few
days prior to initiating medication, and
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - 42 tablets at a dosage of 550 mg each, which is enough for a
recommended treatment course over 14 days … IBS, rifaximin’s labeled,
recommended dosage is one 550 mg tablet, taken 3 times per day, for 14 days … .2,8 Per approved labeling,
rifaximin dosage for treating IBS is 550 mg, three times per day, for 14 days … diarrhea in adults and children
aged 12 years or older, at a dosage of 200 mg, 3 times per day, for 3 days … they would not have the benefit of the medication, they would be sicker and more prone to losing
days